▲ Peaking
Business
Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump
1sources
1articles
0velocity
+0%since first seen
just nowfirst detected
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (1)
- Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump Investor's Business Daily · 13h ago broke it first
Related trends
▲ Peaking
Business
Planned Texas data centers could emit more greenhouse gases than many countries
▲ Peaking
Business
Chip stocks lead Asia higher ahead of SK Hynix blockbuster US debut
▲ Peaking
Business
World oil demand set for first annual decline since 2020, IEA says
▲ Peaking
Business
South Korea’s SK Hynix raises $26.5bn in record-breaking US IPO
South Korea's SK Hynix has secured $26.5 billion in a record-breaking initial public offering on the US stock market.
🔥 Breakout ↑ Rising
Business
Trump clean energy rollbacks erase $68B in US investment
Recent reports indicate that clean energy rollbacks linked to Donald Trump have erased $68 billion in U.S. investment.
↑ Rising
Business